BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 19273702)

  • 1. Prospective, randomized trial of two different modalities of flushing central venous catheters in pediatric patients with cancer.
    Cesaro S; Tridello G; Cavaliere M; Magagna L; Gavin P; Cusinato R; Zadra N; Franco Zanon G; Zanesco L; Carli M
    J Clin Oncol; 2009 Apr; 27(12):2059-65. PubMed ID: 19273702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective survey on incidence and outcome of Broviac/Hickman catheter-related complications in pediatric patients affected by hematological and oncological diseases.
    Cesaro S; Corrò R; Pelosin A; Gamba P; Zadra N; Fusaro F; Pillon M; Cusinato R; Zampieri C; Magagna L; Cavaliere M; Tridello G; Zanon G; Zanesco L
    Ann Hematol; 2004 Mar; 83(3):183-8. PubMed ID: 15064868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive approach to the prevention of central venous catheter complications: results of 10-year prospective surveillance in pediatric hematology-oncology patients.
    Cesaro S; Cavaliere M; Pegoraro A; Gamba P; Zadra N; Tridello G
    Ann Hematol; 2016 Apr; 95(5):817-25. PubMed ID: 26961934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications of Hickman-Broviac catheters in children with malignancies.
    Perdikaris P; Petsios K; Vasilatou-Kosmidis H; Matziou V
    Pediatr Hematol Oncol; 2008 Jun; 25(5):375-84. PubMed ID: 18569839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central venous catheters and catheter locks in children with cancer: a prospective randomized trial of taurolidine versus heparin.
    Handrup MM; Møller JK; Schrøder H
    Pediatr Blood Cancer; 2013 Aug; 60(8):1292-8. PubMed ID: 23417891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: a randomized double-blind controlled trial in patients with hematologic malignancies.
    van Rooden CJ; Schippers EF; Guiot HF; Barge RM; Hovens MM; van der Meer FJ; Rosendaal FR; Huisman MV
    J Clin Oncol; 2008 Jan; 26(3):428-33. PubMed ID: 18202420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
    Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
    Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer.
    Revel-Vilk S; Yacobovich J; Tamary H; Goldstein G; Nemet S; Weintraub M; Paltiel O; Kenet G
    Cancer; 2010 Sep; 116(17):4197-205. PubMed ID: 20533566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia.
    Handrup MM; Møller JK; Frydenberg M; Schrøder H
    Pediatr Blood Cancer; 2010 Aug; 55(2):309-13. PubMed ID: 20582964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Groshong catheter-related complications in children with cancer.
    Ruggiero A; Barone G; Margani G; Nanni L; Pittiruti M; Riccardi R
    Pediatr Blood Cancer; 2010 Jul; 54(7):947-51. PubMed ID: 20162685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, longitudinal study of central venous catheter-related deep venous thrombosis in boys with hemophilia.
    Price VE; Carcao M; Connolly B; Chait P; Daneman A; Temple M; Stain AM; Sung L; Al-Tralbosi H; Blanchette VS
    J Thromb Haemost; 2004 May; 2(5):737-42. PubMed ID: 15099279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients.
    Chan A; Iannucci A; Dager WE
    Ann Pharmacother; 2007 Apr; 41(4):635-41. PubMed ID: 17355999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrochloric acid treatment of tunneled central venous catheter infections in children with cancer.
    Larsen LN; Malchau E; Kristensen B; Schroeder H
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):e64-8. PubMed ID: 21285898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of heparinization in prolonging patency of arterial and central venous catheters in children: a randomized double-blind trial.
    de Neef M; Heijboer H; van Woensel JB; de Haan RJ
    Pediatr Hematol Oncol; 2002 Dec; 19(8):553-60. PubMed ID: 12487830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease.
    Abdelkefi A; Torjman L; Ladeb S; Othman TB; Achour W; Lakhal A; Hsairi M; Kammoun L; Hassen AB; Abdeladhim AB
    J Clin Oncol; 2005 Nov; 23(31):7864-70. PubMed ID: 16258088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tunnelled central venous catheters in children with cancer. Removal and duration].
    Schrøder H; Malchau E; Larsen LN; Bugge K; Olsen H; Kamperis K
    Ugeskr Laeger; 2008 Jan; 170(5):343-7. PubMed ID: 18252163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venous thromboembolism associated with long-term use of central venous catheters in cancer patients.
    Verso M; Agnelli G
    J Clin Oncol; 2003 Oct; 21(19):3665-75. PubMed ID: 14512399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infectious complications of implantable ports and Hickman catheters in paediatric haematology-oncology patients.
    Adler A; Yaniv I; Steinberg R; Solter E; Samra Z; Stein J; Levy I
    J Hosp Infect; 2006 Mar; 62(3):358-65. PubMed ID: 16377030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilumen central venous catheters increase risk for catheter-related bloodstream infection: prospective surveillance study.
    Templeton A; Schlegel M; Fleisch F; Rettenmund G; Schöbi B; Henz S; Eich G
    Infection; 2008 Aug; 36(4):322-7. PubMed ID: 18663408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal saline (0.9% sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long-term central venous catheters in infants and children.
    Bradford NK; Edwards RM; Chan RJ
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD010996. PubMed ID: 32352563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.